Skip to content

KRAKacquisition KRAQ Business Segments — Deferred Offering Costs

Similar metrics at other companies

Bain Capital Specialty Finance logo
BCSFDeferred offering costs
$3.29M-24.2%
Evommune
 logo
EVMNDeferred Offering Cost
-$577.47K
Oaktree Specialty Lending logo
OCSLDeferred offering costs
$43K-73.3%
Immix Biopharma, Inc. logo
IMMXDeferred offering costs
$164.72K
Oaktree Specialty Lending logo
OCSLDeferred offering costs
$33K
Cardinal Infrastructure Group, Inc.
 logo
CDNLAccrued Deferred Offering Costs
-$97.28K

Other financials

Income statement

See full
Operating income-$11.0M
Net income-$8.9M
EPS (diluted)-$0.01

Balance sheet

See full
Cash & equivalents$824.6K
Total debt$77.4K
Total equity-$19.9M
Total assets$348.0M

Cash flow

See full
Operating cash flow-$669.9K

Valuation

See full
Market cap$430.77M+0.9%
Enterprise value$430.02M

Returns & leverage

See full
Debt / equity-0×
Current ratio7.7×

Where this comes from

Reported directly by KRAKacquisition in its filing.

Tagged under the XBRL concept us-gaap:DeferredOfferingCosts.

The official record: KRAKacquisition ’s 10-Q, filed May 15, 2026, on SEC EDGAR. View the filing →

Ask your AI about KRAKacquisition 's business segments — deferred offering costs.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is KRAKacquisition 's business segments — deferred offering costs?
KRAKacquisition (KRAQ) reported business segments — deferred offering costs of $0 in Q1 2026.
What does business segments — deferred offering costs mean?
Captures the direct costs incurred in connection with the issuance of equity or debt securities that are capitalized and amortized over the life of the instrument or offset against proceeds. These costs represent the investment made to secure capital market access. Monitoring these costs helps evaluate the efficiency of the company's capital raising activities.